GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FDPS, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PPARA, TRPV1 |
10.354 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, PPARA, SMAD3, SRC, TEK, TRPV1, XDH |
9.93098 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.94178 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NR3C1, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
8.90416 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.80653 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FDPS, FUT7, GLO1, HSPA1A, MIF, PIM1, PPARA, TYR, XDH |
8.65577 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MIF, PIM1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.03012 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR, XDH |
7.41562 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, NR3C1, PPARA, SRC, TEK, TRPV1 |
7.41329 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
7.37127 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
7.36196 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.34894 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, PPARA, SMAD3, SRC, TEK |
7.14033 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NR3C1, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
7.11659 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, IGF1R, INSR, NR3C1, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.96718 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, HSD17B2, IGF1R, INSR, NR3C1, PPARA, SRC, TEK, TRPV1, TYR |
6.92353 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, SMAD3, SRC, TEK |
6.87465 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.82265 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APEX1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.61897 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.27358 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FDPS, FUT7, MET, MIF, PPARA |
6.27167 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
6.27167 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, NR3C1, SRC, TEK, TRPV1, TYR |
6.14283 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, PIM1, SMAD3, SRC, TEK |
6.14283 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, CSNK2A1, CYP1B1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
6.07608 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, HSD11B1, HSD17B1, HSD17B2 |
5.99458 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.96708 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
5.90541 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.90011 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.89565 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APEX1, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
5.89565 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.84837 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HSD11B1, HSD17B1, HSD17B2, MIF |
5.76369 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, SRC |
5.62294 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.61697 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APEX1, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
5.57626 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, INSR, KDR, MET, MIF, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TYR |
5.55399 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, SRC, TEK, XDH |
5.49011 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, NUAK1, SRC, TEK, XDH |
5.41327 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, SRC, TYR |
5.41276 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NR3C1, NUAK1, SMAD3, SRC, TOP2A, TRPV1 |
5.399 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
5.38547 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
5.34209 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
5.24453 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
5.23507 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
5.22777 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
5.21585 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APEX1, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
5.21585 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APEX1, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
5.2033 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
5.19714 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.18999 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APEX1, AXL, CA12, CA2, CA7, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TRPV1 |
5.18999 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
5.17104 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
5.14229 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, CYP1A1, CYP1B1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
5.10939 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.09382 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
4.98354 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
4.90114 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, NR3C1, NUAK1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR |
4.88429 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HSD11B1, HSD17B1, HSD17B2 |
4.72581 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR, XDH |
4.71529 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
4.67168 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, NR3C1, SRC, TRPV1 |
4.59875 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA |
4.42516 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.25379 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
4.20705 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
4.16756 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
4.12073 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, TYR |
4.10208 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, CYP19A1, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
4.07435 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, FDPS, TYR |
4.06129 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR, XDH |
4.0217 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
4.00202 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
3.99898 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1 |
3.904 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
3.904 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS |
3.89612 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, EGFR, FLT3, NR3C1, SRC, TRPV1 |
3.89313 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.89313 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, SRC |
3.88515 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
3.86976 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
3.82536 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FDPS, FLT3, HCAR2, PPARA, SRC, TEK |
3.79621 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, EGFR, HCAR2, KDR, MIF, SRC, TRPV1 |
3.79325 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, SRC, TRPV1 |
3.77264 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PPARA |
3.76819 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
3.6958 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MIF, MMP12, SRC, TRPV1 |
3.63608 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1, TYR |
3.63608 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
3.6225 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS |
3.56338 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, EGFR, FLT3, INSR, KDR, MIF, SRC, TEK, XDH |
3.54142 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, EGFR, FABP4, KDR, MET, MIF, MMP12, PPARA, SMAD3, TEK |
3.5199 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.51377 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, CA12, CA2, CA7, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3, TRPV1 |
3.48419 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
3.47392 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, MIF, MMP12, PPARA, SMAD3, SRC, TRPV1 |
3.44365 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK, XDH |
3.42968 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, HSD17B2, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
3.41779 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CYP19A1, EGFR, HCAR2, INSR, MIF, MMP12, SMAD3, SRC, TRPV1 |
3.41284 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FDPS, TYR |
3.41284 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, CYP19A1, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
3.40248 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.37545 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1, TYR |
3.36519 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.35638 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, EGFR, HSPA1A, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
3.25196 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, MIF |
3.25196 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, AXL, CA2, CYP1B1, EGFR, HCAR2, HSPA1A, KDR, MET, MIF, MMP12, PIM1, SMAD3, SRC, TEK, TRPV1 |
3.25196 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, FDPS, MIF |
3.24004 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.22828 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, EGFR, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.22508 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
3.19737 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.19305 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
3.18325 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK |
3.18104 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
3.13969 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, EGFR, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.12355 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
3.12355 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.11414 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.11414 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.10902 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, TRPV1, XDH |
3.10618 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MIF, MMP12, PIM1, TEK |
3.10232 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.10232 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.10121 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.08462 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, EGFR, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.05262 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.05182 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.00969 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MIF, MMP12, SRC |
3.00087 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.99155 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.99155 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.99155 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, TRPV1, XDH |
2.97373 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MIF, NUAK1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1 |
2.97247 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, EGFR, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.95725 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.95455 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CYP1A1, DUSP3, EGFR, INSR, MIF, SRC |
2.93109 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
2.93109 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, SRC |
2.92207 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.92207 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.92207 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.92207 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.92207 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.90404 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.90404 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.88636 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.88157 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.86881 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.86467 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, MIF, SRC, TEK |
2.86108 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, SRC, TEK, TRPV1 |
2.82258 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, MIF, PPARA, SMAD3, TEK |
2.81697 |
[BP] GO:0070848 |
response to growth factor
|
EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
2.81697 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.81243 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.81194 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.8023 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
2.79594 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.7594 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.75234 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.75234 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, GLO1, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.75234 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.75234 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.7499 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.7287 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TOP2A |
2.71863 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, AXL, CA2, CYP1B1, EGFR, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, PIM1, SMAD3, SRC, TEK, TRPV1, XDH |
2.71588 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.71588 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1, XDH |
2.71588 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, KDR, MIF, SRC, TEK |
2.69457 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, EGFR, FLT3, IGF1R, INSR, NR3C1, SMAD3, SRC, TRPV1 |
2.69355 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.68301 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.68301 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, MET, TRPV1 |
2.67418 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.64091 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.63695 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.63695 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.60088 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, AURKB, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.58711 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, KDR, SRC, TRPV1 |
2.58711 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.58711 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.57636 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP12, SRC, XDH |
2.49889 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, NR3C1, SRC |
2.47659 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.46677 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.42229 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.42229 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3 |
2.3938 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, IGF1R, INSR, NR3C1, SRC, TRPV1 |
2.38741 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, AURKB, CSNK2A1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.38741 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38594 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38594 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, AURKB, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.38432 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, SMAD3, SRC, XDH |
2.36788 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.36074 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, EGFR, FABP3, FLT3, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
2.36074 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, EGFR, FABP3, FLT3, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
2.36074 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, SMAD3, SRC, XDH |
2.36074 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.35587 |
[BP] GO:0050714 |
None
|
ACHE, EGFR, HCAR2, MIF, MMP12, SRC |
2.34797 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.34785 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.34785 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK |
2.34193 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.31904 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, PPARA, SRC, TEK, XDH |
2.30575 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.29525 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.29525 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, HCAR2, MIF, MMP12, SRC |
2.28651 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.28651 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP12, PPARA, SMAD3, SRC, TEK |
2.27145 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.26802 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK, TRPV1 |
2.26802 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, CA2, CA9, CYP1B1, EGFR, HSPA1A, MIF, NUAK1, SRC, TOP2A, TRPV1 |
2.25399 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, MIF |
2.23143 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, NR3C1, SRC |
2.22253 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.22253 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.22253 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, MIF |
2.22253 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
2.20445 |
[BP] GO:1901655 |
None
|
AKR1B1, EGFR, NR3C1, SRC |
2.20445 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.20372 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.20372 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, INSR, SMAD3, TRPV1 |
2.20372 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, MIF |
2.19547 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF |
2.19547 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.19547 |
[BP] GO:1903426 |
None
|
EGFR, INSR, SMAD3, TRPV1 |
2.19547 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.19547 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, IGF1R, MET, PIM1, PPARA, SRC |
2.18739 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NUAK1, SRC, TEK, XDH |
2.18166 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, CSNK2A1, DUSP3, EGFR, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PPARA, SMAD3, SRC, TRPV1, XDH |
2.18166 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.17968 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.17739 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.17739 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.17447 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.14885 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, MIF, SRC |
2.1426 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.1426 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF |
2.13645 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
2.13623 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.12135 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, FABP4, PPARA, SMAD3, TEK |
2.11394 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.11043 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.11043 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HSPA1A |
2.09799 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
2.09799 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.09739 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.09739 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.09739 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.09739 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.0861 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, INSR, SRC, TRPV1 |
2.0848 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
2.0776 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.07141 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, KDR, MET, MIF, SMAD3 |
2.04143 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF |
2.03428 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET |
2.03092 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.02289 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, MET, SMAD3, SRC |
2.02289 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CSNK2A1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, MIF, NUAK1, SMAD3, SRC, TEK, XDH |
2.02289 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DUSP3, MIF, MMP12 |
2.02289 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, PPARA, SRC, TOP2A |
2.00857 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR, XDH |
2.00789 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.8023 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, FLT3, GLO1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PIM1, SMAD3, SRC, TEK, TRPV1 |
2.57503 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PIM1, SMAD3, SRC, TEK, TRPV1, TYR |
2.22253 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, AURKB, CA1, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MIF, NR3C1, PIM1, SMAD3, SRC, TOP2A, TRPV1, TYR, XDH |
2.08768 |
[CC] GO:0032589 |
None
|
ADORA1, INSR, TRPV1 |
1.87969 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, SRC, TEK, TOP2A, TYR, XDH |
10.8929 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3294 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FDPS, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR, XDH |
9.93098 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP12, NR3C1, PIM1, PPARA, SMAD3, TYR, XDH |
9.81454 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.85869 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.34894 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.18687 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A, TRPV1 |
7.11659 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.82265 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
6.29699 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
6.14283 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.95155 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.90541 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.63281 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.41276 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, GLO1, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, TOP2A, TRPV1, TYR, XDH |
5.1037 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
5.09382 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, GLO1, MMP12, NR3C1, NUAK1, PIM1, PPARA, SMAD3, TOP2A, TRPV1, TYR, XDH |
4.71529 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
4.41058 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.3456 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.24167 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.15211 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, PPARA, SMAD3, SRC |
3.96943 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.88515 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
3.58429 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.51425 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.49004 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.49004 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
3.48419 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
3.43548 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.37545 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
3.33562 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
3.30155 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.22508 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, TEK, TRPV1 |
3.18104 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.13824 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.99155 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
2.96873 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
2.86881 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
2.86842 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.86108 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, SMAD3, TEK, TRPV1 |
2.79985 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP12, NR3C1, PPARA, SMAD3 |
2.78966 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, TEK, TRPV1 |
2.69898 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.63695 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.63695 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.63695 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, TEK, TRPV1 |
2.57194 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.56554 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.5004 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.45486 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.45486 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.45319 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.42229 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, HSD11B1, HSD17B1, HSD17B2, XDH |
2.42229 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.41938 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.38594 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.38594 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.34785 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.30575 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.30575 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.29543 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.25946 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.23143 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.23143 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.22253 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.22253 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.1426 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, FABP3, FABP4, HSD17B1, NR3C1, PPARA, TRPV1 |
2.10631 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.09739 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.0861 |